Nicola Personeni

Humanitas University

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Anwaar Saeed

University of Pittsburgh

UNITED STATES

View details

Johann von Felden

University Medical Center Hamburg-Eppendorf

GERMANY

View details

David J. Pinato

Imperial College London

UNITED KINGDOM

View details

Valeria Pessei

Candiolo Cancer Institute

ITALY

View details

luca di tommaso

Associate professor of Pathology

Humanitas University

ITALY

View details

Giovanni Germano

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Antonio D'Alessio

Imperial College London

UNITED KINGDOM

View details

Alessandro Cavaliere

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicola Personeni

Research Interests

Explore related searches

Contact this professor

Articles (11)

A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection

Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials

The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials

Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.

Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.

Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study

Collaborators (8)

Anwaar Saeed

Johann von Felden

David J. Pinato

Valeria Pessei

luca di tommaso

Giovanni Germano

Antonio D'Alessio

Alessandro Cavaliere

Make your next move.